Green Thumb Industries (GTBIF) Gains from Sales and Divestitures (2021 - 2026)
Green Thumb Industries (GTBIF) reported Gains from Sales and Divestitures of $1.4 million for Q1 2026, up 159.58% on a YoY basis from $548305.0 in Q1 2025, and down 31.26% quarter-over-quarter from $2.1 million in Q4 2025.
Green Thumb Industries (GTBIF) Gains from Sales and Divestitures (2021 - 2026) Analysis & Trends
Green Thumb Industries has reported Gains from Sales and Divestitures for 6 years, with the latest figure at $1.4 million in Q1 2026.
- For the quarter ending Q1 2026, Gains from Sales and Divestitures rose 159.58% year-over-year to $1.4 million; the trailing twelve-month figure through Mar 2026 stood at $1.4 million (up 159.58% YoY), and the FY2025 full-year result was $2.1 million, up 99.51% from the prior year.
- Gains from Sales and Divestitures for Q1 2026 stood at $1.4 million, down from $2.1 million in the prior quarter.
- The five-year high for Gains from Sales and Divestitures was $2.1 million in Q4 2025, with the low at $75620.0 in Q1 2023.
- Historically, Gains from Sales and Divestitures has averaged $700506.4 across 5 years, with a median of $451138.0 in 2023.
- Annual changes were most pronounced in 2023 — Gains from Sales and Divestitures fell 29.75% — and 2025, when it soared 410.51%.
- Green Thumb Industries' Gains from Sales and Divestitures stood at $433341.0 in 2022, then rose by 4.11% to $451138.0 in 2023, then surged by 130.04% to $1.0 million in 2024, then surged by 99.51% to $2.1 million in 2025, then sank by 31.26% to $1.4 million in 2026.
- The last three Gains from Sales and Divestitures figures came in at $1.4 million (Q1 2026), $2.1 million (Q4 2025), and $1.3 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.77 Bn | 35.04 Bn | 1.97 Bn |
| 2 | Zoetis | 34.11 Bn | 32.16 Bn | 1.62 Bn |
| 3 | United Therapeutics | 23.68 Bn | 21.53 Bn | 648.10 Mn |
| 4 | Aurora Cannabis | 16.48 Bn | 16.40 Bn | 33.43 Mn |
| 5 | Neurocrine Biosciences | 16.19 Bn | 14.88 Bn | 800.70 Mn |
| 6 | Elanco Animal Health | 11.44 Bn | 11.01 Bn | 785.00 Mn |
| 7 | Alkermes | 7.28 Bn | 6.77 Bn | -116.06 Mn |
| 8 | Lantheus Holdings | 6.48 Bn | 5.98 Bn | 230.92 Mn |
| 9 | Hims & Hers Health | 6.35 Bn | 5.60 Bn | 396.79 Mn |
| 10 | Green Thumb Industries | - | - | 143.65 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.42 Mn |
| Mar 31, 2026 | 1.42 Mn |
| Dec 31, 2025 | 2.07 Mn |
| Dec 31, 2025 | 2.07 Mn |
| Sep 30, 2025 | 1.30 Mn |
| Sep 30, 2025 | 1.30 Mn |
| Jun 30, 2025 | 1.18 Mn |
| Jun 30, 2025 | 1.18 Mn |
| Mar 31, 2025 | 548,305.00 |
| Mar 31, 2025 | 548,305.00 |
| Dec 31, 2024 | 1.04 Mn |
| Dec 31, 2024 | 1.04 Mn |
| Sep 30, 2024 | 905,176.00 |
| Sep 30, 2024 | 905,176.00 |
| Jun 30, 2024 | 804,440.00 |
| Jun 30, 2024 | 804,440.00 |
| Mar 31, 2024 | 107,404.00 |
| Mar 31, 2024 | 107,404.00 |
| Dec 31, 2023 | 451,138.00 |
| Dec 31, 2023 | 451,138.00 |